To confirm the role of p38/MAPK and JNK/MAPK pathways in the daphnegiravone D caused inhibitory effect on hepatoma cell, SB203580 (a p38/MAPK specific inhibitor) and SP600125 (a JNK/MAPK specific inhibitor) were applied. Here, MAPK8 is linked to hepatocellular carcinoma.